AGP Picks
View all

Fresh news on health and wellness in Washington, D.C.

Provided by AGP

Potomac Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Potomac Health News.

Press releases published on April 15, 2026

Aerska Strengthens Leadership and Board with Key Appointments to Advance Systemically Delivered RNA Medicines for the Brain
Citryll Strengthens Intellectual Property Portfolio With Grant of European Composition of Matter Patent for CIT-013
OSE Immunotherapeutics to Present a Novel, First-in-Class, FPR2 Agonist Monoclonal Antibody in the Resolution of Chronic Inflammation  at the AAI 2026 Meeting
OSE Immunotherapeutics présentera un nouvel anticorps monoclonal,  first-in-class, agoniste de FPR2 dans la résolution de l’inflammation chronique  au Congrès 2026 de l’AAI
BioVersys to Present Data on Clinical and Preclinical Pipeline Programs at ESCMID Global 2026
Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes
Spyre Therapeutics Announces Pricing of Upsized $403.0 Million Public Offering of Common Stock
LECOM Makes Pharmacy Education More Accessible with Three Fully Accredited Doctor of Pharmacy Pathways
Allogene Therapeutics Announces Pricing of Public Offering of Common Stock
American Addiction Centers and Filmmaker Jeffrey Shulman Team Up to Promote Powerful New Film on Addiction and Recovery with National Theatrical Tour
Arc TRT Launches New Website to Help UK Men Access Personalised Testosterone Replacement Therapy
EpimAb Biotherapeutics to Present a Novel Prodrug T-Cell Engager (ProTCE) Platform at the 2026 American Association for Cancer Research Annual Meeting
Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products

Share us

on your social networks:

Sign up for:

Potomac Health News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.